Department of Sciences and Technologies, University of Sannio, Benevento, Italy.
CEINGE Advanced Biotechnologies s.c.a.r.l., Naples, Italy.
Front Endocrinol (Lausanne). 2022 Mar 18;13:858330. doi: 10.3389/fendo.2022.858330. eCollection 2022.
Cardiovascular disease (CVD) is still the leading cause of death worldwide. Despite successful advances in both pharmacological and lifestyle strategies to fight well-established risk factors, the burden of CVD is still increasing. Therefore, it is necessary to further deepen our knowledge of the pathogenesis of the disease for developing novel therapies to limit even more its related morbidity and mortality. Oxidative stress has been identified as a common trait of several manifestations of CVD and could be a promising target for innovative treatments. Mitochondria are a major source of oxidative stress and sirtuins are a family of enzymes that generate different post-translational protein modifications, thus regulating important cellular processes, including cell cycle, autophagy, gene expression, and others. In particular, three sirtuins, SIRT3, SIRT4, and SIRT5 are located within the mitochondrial matrix where they regulate energy production and antioxidant pathways. Therefore, these sirtuins are strongly involved in the balance between oxidant and antioxidant mechanisms. In this review, we summarize the activities of these sirtuins with a special focus on their role in the control of oxidative stress, in relation to energy metabolism, atherosclerosis, and CVD.
心血管疾病(CVD)仍然是全球范围内的主要死亡原因。尽管在药物治疗和生活方式策略方面都取得了成功,可以对抗已确立的风险因素,但 CVD 的负担仍在增加。因此,有必要进一步加深对疾病发病机制的了解,以开发新的治疗方法,进一步降低相关发病率和死亡率。氧化应激已被确定为几种 CVD 表现的共同特征,可能是创新治疗的有前途的靶点。线粒体是氧化应激的主要来源,而沉默调节蛋白是产生不同翻译后蛋白修饰的酶家族,从而调节包括细胞周期、自噬、基因表达等在内的重要细胞过程。特别是,三种沉默调节蛋白,SIRT3、SIRT4 和 SIRT5,位于线粒体基质内,调节能量产生和抗氧化途径。因此,这些沉默调节蛋白强烈参与氧化应激和抗氧化机制之间的平衡。在这篇综述中,我们总结了这些沉默调节蛋白的活性,特别关注它们在控制氧化应激方面的作用,以及与能量代谢、动脉粥样硬化和 CVD 的关系。